• Skip to navigation
  • Skip to content

Navigation

  • Preface
    • About us
    • History
  • Experts' section
    • About myeloma
      • Odhaľme rakovinu krvi
    • Recomendations for MM
    • RMG
    • Myeloma forum
      • Myeloma forum 2017
        • Published presentations
    • Publications
  • Patients' section
    • What is myeloma
    • Patients' club SMyS
    • Myeloma school for patients
      • Myeloma school for patients 2017
        • Presentations
    • Psychological guidance
    • Social - legal guidance
    • Hematological guidance
    • Reports from experts' meetings
  • DMM
    • Multiple myeloma day 2018
    • Multiple myeloma day 2017
    • Multiple myeloma day 2016
  • MPE
  • IMF
  • Partners
  • Support us
    • 2% of income tax
    • Support of the Public
  • Membership
  • Contacts

    ​ News

    ​
    Sum of membership contribution 2022

    In conformity with the statutes of the Slovak Myeloma Society (SMyS)...

    04.11. 2022
    Myeloma school for patients 2022

    09 – 10 September 2022, MYELOMA SCHOOL FOR PATIENTS

    01.09. 2022

    ​ We are member of

    Publications

     

    Efficacy and safety of pomalidomide in relapsedrefractory multiple myeloma a retrospective analysis of the first Slovak patients.pdf

    Monoklonové gamapatie.pdf

    Tlejúci (smoldering) mnohopočetný myelóm.pdf

    Diagnostické a prognostické faktory pri mnohopočetnom myelóme.pdf

    Liečba mnohopočetného myelómu.pdf

    Monoklonové protilátky v liečbe mnohopočetného myelómu.pdf

    Waldenströmova makroglobulinémie v roce 2016: optimalizace imunochemoterapie s cílem mnimalizace nežádoucích účinků.pdf

    Systémová amyloidóza.pdf

    Slovenská myelómová spoločnosť.pdf


    © 2016 Slovenská myelómová spoločnosť all rights reserved